– моментальные уведомления о рынке акций
– моментальные уведомления о рынке акций
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended March 31, 2022 and 2021:
KING OF PRUSSIA, Pa., April 25, 2022 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $153.9 million, or $2.02 per diluted share, during the first quarter of 2022, as compared to $209.1 million, or $2.43 per diluted share, during the first quarter of 2021. Net revenues increased by 9.3% to $3.293 billion during the first quarter of 2022 as compared to $3.013 billion during the first quarter of 2021.
As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our adjusted net income attributable to UHS during the first quarter of 2022 was $163.5 million, or $2.15 per diluted share, as compared to $210.1 million, or $2.44 per diluted share, during the first quarter of 2021.
As reflected on the Supplemental Schedule, included in our reported results during the first quarter of 2022, was an unfavorable after-tax unrealized loss of $9.5 million, or $.13 per diluted share, ($12.5 million pre-tax which is included in "Other (income) expense, net"), resulting from a decrease in the market value of certain equity securities.
As reflected on the Supplemental Schedule, included in our reported results during the first quarter of 2021, was a net aggregate unfavorable after-tax impact of $1.1 million, or $.01 per diluted share, consisting of the following: (i) an after-tax unrealized loss of $2.1 million, or $.02 per diluted share, ($2.8 million pre-tax which is included in "Other (income) expense, net"), resulting from a decrease in the market value of certain equity securities, and; (ii) a favorable after-tax impact of $1.1 million, or $.01 per diluted share, resulting from ASU 2016-09, "Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09").
As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization ("EBITDA net of NCI", NCI is net income attributable to noncontrolling interests), was $368.3 million during the first quarter of 2022, as compared to $426.3 million during the first quarter of 2021. Our adjusted earnings before interest, taxes, depreciation & amortization ("Adjusted EBITDA net of NCI"), which excludes the impact of other (income) expense, net, was $379.5 million during the first quarter of 2022, as compared to $427.1 million during the first quarter of 2021.
Acute Care Services – Three-month periods ended March 31, 2022 and 2021:
During the first quarter of 2022, at our acute care hospitals owned during both periods ("same facility basis"), adjusted admissions (adjusted for outpatient activity) increased by 5.7% and adjusted patient days increased by 5.5%, as compared to the first quarter of 2021. At these facilities, during the first quarter of 2022, net revenue per adjusted admission increased by 3.1% and net revenue per adjusted patient day increased by 3.3%, as compared to the first quarter of 2021. Net revenues generated from our acute care services on a same facility basis increased by 9.7% during the first quarter of 2022, as compared to the first quarter of 2021.
Behavioral Health Care Services – Three-month periods ended March 31, 2022 and 2021:
During the first quarter of 2022, at behavioral health care facilities on a same facility basis, adjusted admissions decreased by 1.9% and adjusted patient days decreased by 1.3%, as compared to the first quarter of 2021. At these facilities, during the first quarter of 2022, net revenue per adjusted admission increased by 5.8% and net revenue per adjusted patient day increased by 5.1%, as compared to the first quarter of 2021. Net revenues generated from our behavioral health care services increased by 3.8% during the first quarter of 2022, as compared to the first quarter of 2021.
The impact of the COVID-19 pandemic, which began during the second half of March, 2020, has had a material effect on our operations and financial results since that time. The COVID-19 vaccination process commenced during the first quarter of 2021. Since that time through the second quarter of 2021, we had generally experienced a decline in COVID-19 patients as well as a corresponding recovery in non-COVID patient activity. However, during the third and fourth quarters of 2021, and continuing into the early part of the first quarter of 2022, our facilities generally experienced an increase in COVID-19 patients resulting from the Delta and, more recently, the highly transmissible Omicron variants. COVID-19 related patient volumes at our facilities were generally declining during the latter part of the first quarter of 2022.
The nationwide shortage of nurses and other clinical staff and support personnel has been a significant operating issue facing us and other healthcare providers. Like others in the healthcare industry, we continue to experience a shortage of nurses and other clinical staff and support personnel at our acute care and behavioral health care hospitals in many geographic areas. In some areas, the labor scarcity is putting a strain on our resources and staff, which has required us to utilize higher–cost temporary labor and pay premiums above standard compensation for essential workers. This staffing shortage has required us to hire expensive temporary personnel and/or enhance wages and benefits to recruit and retain nurses and other clinical staff and support personnel. At certain facilities, particularly within our behavioral health care segment, we have been unable to fill all vacant positions and, consequently, have been required to limit patient volumes. These factors had a material unfavorable impact on our results of operations during the first quarter of 2022. The length and extent of the disruptions caused by the COVID–19 pandemic are currently unknown; however, we expect such disruptions to continue during 2022.
Since the future volumes and severity of COVID-19 patients remain highly uncertain and subject to change, including potential increases in future COVID-19 patient volumes caused by new variants of the virus, as well as related pressures on staffing and wage rates, we are not able to fully quantify the impact that these factors will have on our future financial results. However, developments related to the COVID-19 pandemic could continue to materially affect our financial performance during 2022.
Net Cash Provided by Operating Activities and Liquidity:
Net Cash Provided by Operating Activities:
For the three months ended March 31, 2022, our net cash provided by operating activities was $445 million as compared to $72 million during the first quarter of 2021. The $374 million net increase in our net cash provided by operating activities during the first quarter of 2022, as compared to the first quarter of 2021, was due to: (i) a favorable change of $510 million resulting primarily from the early return of Medicare accelerated payments which were received during 2020 and repaid during the first quarter of 2021, partially offset by; (ii) an unfavorable change of $72 million in accounts receivable; (iii) an unfavorable change of $44 million resulting from a decrease in net income plus depreciation and amortization expense, stock-based compensation expense and gain/loss on sales of assets and businesses, and; (iv) $20 million of other combined net unfavorable changes.
As of March 31, 2022, we had $736 million of aggregate available borrowing capacity pursuant to our $1.2 billion revolving credit facility, net of outstanding borrowings and letters of credit.
Stock Repurchase Program:
As previously announced, on February 24, 2022, our Board of Directors authorized a $1.4 billion increase to our stock repurchase program. Pursuant to this program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions.
During the first quarter of 2022, we have repurchased approximately 2.65 million shares at an aggregate cost of approximately $350.2 million (approximately $132 per share). As of March 31, 2022, we had an aggregate available repurchase authorization of approximately $1.41 billion.
2022 Operating Results Forecast:
On February 24, 2022, we provided our 2022 operating results forecast as part of our 2021 fourth quarter and full year financial results' announcement. As disclosed at that time, since the future volumes and severity of COVID-19 patients remain highly uncertain and subject to change, as well as pressures on staffing and wage rates, we are not able to fully quantify the impact that these factors will have on our future financial results.
Our operating results during the first quarter of 2022 reflect continued uncertainties related to the COVID-19 pandemic as well cost escalations related to the nationwide shortage of nurses and other clinical staff and support personnel. As a result, our labor costs were higher than anticipated, and patient volumes at our behavioral health care facilities were lower than anticipated, which unfavorably impacted our operating results during the first quarter of 2022.
At this time, we are not changing our previously released 2022 operating results forecast. However, given the continued uncertainties related to the COVID-19 pandemic, as well as the healthcare staffing shortage and its unfavorable impact on our labor costs and behavioral health patient volumes, we may make reductions to our 2022 full year operating results forecast at a future date if the unfavorable operating trends experienced during the first quarter of 2022 do not improve.
Conference call information:
We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on April 26, 2022. The dial-in number is 1-877-648-7971.
A live broadcast of the conference call will be available on our website at www.uhs.com. Also, a replay of the call will be available following the conclusion of the live call and will be available for one full year.
General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:
One of the nation's largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500 corporation, our annual revenues during 2021 were approximately $12.6 billion. In 2022, UHS was again recognized as one of the World's Most Admired Companies by Fortune; and in 2021 the Company ranked #270 on the Fortune 500 and #307 on Forbes' list of America's Largest Public Companies.
Our operating philosophy is as effective today as it was upon the Company's founding in 1979, enabling us to provide compassionate care to our patients and their loved ones. Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.
Headquartered in King of Prussia, PA, UHS has over 89,000 employees and through its subsidiaries operates 28 acute care hospitals (including the newly constructed, 170-bed Northern Nevada Sierra Medical Center located in Reno, Nevada, which opened in early April, 2022), 336 behavioral health facilities, 40 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 39 U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT). For additional information visit www.uhs.com.
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to the anticipated impact of COVID-19 on our operations and financial results, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk Factors in our Form 10-K for the year ended December 31, 2021), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Many of the factors that could affect our future results are beyond our control or ability to predict, including the impact of the COVID-19 pandemic. Our future operations and financial results will likely be materially impacted by developments related to COVID-19 including, but not limited to, the potential impact on future COVID-19 patient volumes resulting from new variants of the virus, the length of time and severity of the spread of the pandemic; the volume of cancelled or rescheduled elective procedures and the volume of COVID-19 patients treated at our hospitals and other healthcare facilities; measures we are taking to respond to the COVID-19 pandemic; the impact of government and administrative regulation and stimulus on the hospital industry and potential retrospective adjustment in future periods of CARES Act and other grant income revenues recorded as revenues in prior periods; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions to our clinical staffing and shortages and disruptions related to supplies required for our employees and patients; potential increases to expenses and other costs related to staffing, supply chain, construction and medical equipment costs and other expenditures resulting from inflation; the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financing perspective; and changes in general economic conditions nationally and regionally in our markets resulting from the COVID-19 pandemic. We are not able to fully quantify the impact that these factors will have on our future financial results, but developments related to the COVID-19 pandemic could continue to materially affect our financial performance during 2022.
We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, changes in the market value of shares of certain equity securities and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2021. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.
Universal Health Services, Inc. |
|||
Consolidated Statements of Income |
|||
(in thousands, except per share amounts) |
|||
(unaudited) |
|||
Three months |
|||
ended March 31, |
|||
2022 |
2021 |
||
Net revenues |
$3,292,956 |
$3,012,987 |
|
Operating charges: |
|||
Salaries, wages and benefits |
1,692,270 |
1,497,773 |
|
Other operating expenses |
820,934 |
709,708 |
|
Supplies expense |
371,073 |
347,110 |
|
Depreciation and amortization |
143,784 |
131,403 |
|
Lease and rental expense |
32,038 |
31,324 |
|
3,060,099 |
2,717,318 |
||
Income from operations |
232,857 |
295,669 |
|
Interest expense, net |
21,673 |
21,957 |
|
Other (income) expense, net |
11,201 |
835 |
|
Income before income taxes |
199,983 |
272,877 |
|
Provision for income taxes |
48,962 |
63,807 |
|
Net income |
151,021 |
209,070 |
|
Less: Net income (loss) attributable to |
|||
noncontrolling interests ("NCI") |
(2,892) |
(21) |
|
Net income attributable to UHS |
$153,913 |
$209,091 |
|
Basic earnings per share attributable to UHS (a) |
$2.05 |
$2.46 |
|
Diluted earnings per share attributable to UHS (a) |
$2.02 |
$2.43 |
|
Universal Health Services, Inc. |
|||
Footnotes to Consolidated Statements of Income |
|||
(in thousands, except per share amounts) |
|||
(unaudited) |
|||
Three months |
|||
(a) Earnings per share calculation: |
ended March 31, |
||
2022 |
2021 |
||
Basic and diluted: |
|||
Net income attributable to UHS |
$153,913 |
$209,091 |
|
Less: Net income attributable to unvested restricted share grants |
(249) |
(552) |
|
Net income attributable to UHS - basic and diluted |
$153,664 |
$208,539 |
|
Weighted average number of common shares - basic |
75,030 |
84,782 |
|
Basic earnings per share attributable to UHS: |
$2.05 |
$2.46 |
|
Weighted average number of common shares |
75,030 |
84,782 |
|
Add: Other share equivalents |
1,011 |
1,014 |
|
Weighted average number of common shares and equiv. - diluted |
76,041 |
85,796 |
|
Diluted earnings per share attributable to UHS: |
$2.02 |
$2.43 |
|
Universal Health Services, Inc. |
|||||||
Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule") |
|||||||
For the Three Months ended March 31, 2022 and 2021 |
|||||||
(in thousands, except per share amounts) |
|||||||
(unaudited) |
|||||||
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI") |
|||||||
Three months ended |
% Net |
Three months ended |
% Net |
||||
March 31, 2022 |
revenues |
March 31, 2021 |
revenues |
||||
Net income attributable to UHS |
$153,913 |
$209,091 |
|||||
Depreciation and amortization |
143,784 |
131,403 |
|||||
Interest expense, net |
21,673 |
21,957 |
|||||
Provision for income taxes |
48,962 |
63,807 |
|||||
EBITDA net of NCI |
$368,332 |
11.2% |
$426,258 |
14.1% |
|||
Other (income) expense, net |
11,201 |
835 |
|||||
Adjusted EBITDA net of NCI |
$379,533 |
11.5% |
$427,093 |
14.2% |
|||
Net revenues |
$3,292,956 |
$3,012,987 |
|||||
Calculation of Adjusted Net Income Attributable to UHS |
|||||||
Three months ended |
Three months ended |
||||||
March 31, 2022 |
March 31, 2021 |
||||||
Per |
Per |
||||||
Amount |
Diluted Share |
Amount |
Diluted Share |
||||
Net income attributable to UHS |
$153,913 |
$2.02 |
$209,091 |
$2.43 |
|||
Plus/minus after-tax adjustments: |
|||||||
Unrealized loss on equity securities |
9,537 |
0.13 |
2,137 |
0.02 |
|||
Impact of ASU 2016-09 |
- |
- |
(1,079) |
(0.01) |
|||
Subtotal adjustments |
9,537 |
0.13 |
1,058 |
0.01 |
|||
Adjusted net income attributable to UHS |
$163,450 |
$2.15 |
$210,149 |
$2.44 |
|||
Universal Health Services, Inc. |
|||
Consolidated Statements of Comprehensive Income |
|||
(in thousands) |
|||
(unaudited) |
|||
Three months |
|||
ended March 31, |
|||
2022 |
2021 |
||
Net income |
$151,021 |
$209,070 |
|
Other comprehensive income (loss): |
|||
Foreign currency translation adjustment |
(18,470) |
(10,346) |
|
Other comprehensive income (loss) before tax |
(18,470) |
(10,346) |
|
Income tax expense (benefit) related to items of other comprehensive income (loss) |
(944) |
(1,466) |
|
Total other comprehensive income (loss), net of tax |
(17,526) |
(8,880) |
|
Comprehensive income |
133,495 |
200,190 |
|
Less: Comprehensive income (loss) attributable to noncontrolling interests |
(2,892) |
(21) |
|
Comprehensive income attributable to UHS |
$136,387 |
$200,211 |
|
Universal Health Services, Inc. |
||||||
Condensed Consolidated Balance Sheets |
||||||
(in thousands) |
||||||
(unaudited) |
||||||
March 31, |
December 31, |
|||||
2022 |
2021 |
|||||
Assets |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
105,999 |
$ |
115,301 |
||
Accounts receivable, net |
1,754,877 |
1,746,635 |
||||
Supplies |
208,302 |
206,839 |
||||
Other current assets |
232,724 |
194,781 |
||||
Total current assets |
2,301,902 |
2,263,556 |
||||
Property and equipment |
10,929,292 |
10,770,702 |
||||
Less: accumulated depreciation |
(5,010,825) |
(4,896,427) |
||||
5,918,467 |
5,874,275 |
|||||
Other assets: |
||||||
Goodwill |
3,949,788 |
3,962,624 |
||||
Deferred income taxes |
47,549 |
45,707 |
||||
Right of use assets-operating leases |
368,921 |
367,477 |
||||
Deferred charges |
6,310 |
6,525 |
||||
Other |
551,509 |
573,379 |
||||
Total Assets |
$ |
13,144,446 |
$ |
13,093,543 |
||
Liabilities and Stockholders' Equity |
||||||
Current liabilities: |
||||||
Current maturities of long-term debt |
$ |
48,486 |
$ |
48,409 |
||
Accounts payable and other liabilities |
1,976,389 |
1,860,496 |
||||
Operating lease liabilities |
65,607 |
64,484 |
||||
Federal and state taxes |
55,734 |
10,720 |
||||
Total current liabilities |
2,146,216 |
1,984,109 |
||||
Other noncurrent liabilities |
475,006 |
464,759 |
||||
Operating lease liabilities noncurrent |
305,643 |
304,624 |
||||
Long-term debt |
4,250,689 |
4,141,879 |
||||
Redeemable noncontrolling interest |
4,314 |
5,119 |
||||
UHS common stockholders' equity |
5,867,872 |
6,089,664 |
||||
Noncontrolling interest |
94,706 |
103,389 |
||||
Total equity |
5,962,578 |
6,193,053 |
||||
Total Liabilities and Stockholders' Equity |
$ |
13,144,446 |
$ |
13,093,543 |
||
Universal Health Services, Inc. |
|||
Consolidated Statements of Cash Flows |
|||
(in thousands) |
|||
(unaudited) |
|||
Three months |
|||
ended March 31, |
|||
2022 |
2021 |
||
Cash Flows from Operating Activities: |
|||
Net income |
$151,021 |
$209,070 |
|
Adjustments to reconcile net income to net |
|||
cash provided by operating activities: |
|||
Depreciation & amortization |
143,784 |
131,403 |
|
Loss on sale of assets and businesses |
1,084 |
0 |
|
Stock-based compensation expense |
19,055 |
18,022 |
|
Changes in assets & liabilities, net of effects from |
|||
acquisitions and dispositions: |
|||
Accounts receivable |
(15,073) |
56,851 |
|
Accrued interest |
180 |
10,133 |
|
Accrued and deferred income taxes |
47,548 |
53,769 |
|
Other working capital accounts |
63,308 |
82,663 |
|
Medicare accelerated payments and deferred CARES Act and other grants |
250 |
(509,448) |
|
Other assets and deferred charges |
26,042 |
(17) |
|
Other |
(4,020) |
2,623 |
|
Accrued insurance expense, net of commercial premiums paid |
41,685 |
35,467 |
|
Payments made in settlement of self-insurance claims |
(29,431) |
(18,741) |
|
Net cash provided by operating activities |
445,433 |
71,795 |
|
Cash Flows from Investing Activities: |
|||
Property and equipment additions |
(200,002) |
(247,459) |
|
Proceeds received from sales of assets and businesses |
10,232 |
0 |
|
Inflows (outflows) from foreign exchange contracts that hedge our net U.K. investment |
20,710 |
(14,264) |
|
Decrease in capital reserves of commercial insurance subsidiary |
100 |
100 |
|
Costs incurred for purchase of information technology applications, net of refunds |
0 |
(575) |
|
Investment in, and advances to, joint ventures and other |
0 |
(129) |
|
Net cash used in investing activities |
(168,960) |
(262,327) |
|
Cash Flows from Financing Activities: |
|||
Repayments of long-term debt |
(11,966) |
(251,830) |
|
Additional borrowings |
117,400 |
0 |
|
Repurchase of common shares |
(365,505) |
(7,464) |
|
Dividends paid |
(14,875) |
(17,018) |
|
Issuance of common stock |
3,503 |
3,357 |
|
Profit distributions to noncontrolling interests |
(5,289) |
(4,525) |
|
Purchase (sale) of ownership interests by (from) minority members |
(1,307) |
7,603 |
|
Net cash used in financing activities |
(278,039) |
(269,877) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(2,232) |
423 |
|
Decrease in cash, cash equivalents and restricted cash |
(3,798) |
(459,986) |
|
Cash, cash equivalents and restricted cash, beginning of period |
178,934 |
1,279,154 |
|
Cash, cash equivalents and restricted cash, end of period |
$175,136 |
$819,168 |
|
Supplemental Disclosures of Cash Flow Information: |
|||
Interest paid |
$20,388 |
$11,421 |
|
Income taxes paid, net of refunds |
$4,423 |
$8,654 |
|
Noncash purchases of property and equipment |
$90,730 |
$60,124 |
|
Universal Health Services, Inc. |
||||||
Supplemental Statistical Information |
||||||
(unaudited) |
||||||
% Change |
||||||
3 Months ended |
||||||
Same Facility: |
3/31/2022 |
|||||
Acute Care Hospitals |
||||||
Revenues |
9.7% |
|||||
Adjusted Admissions |
5.7% |
|||||
Adjusted Patient Days |
5.5% |
|||||
Revenue Per Adjusted Admission |
3.1% |
|||||
Revenue Per Adjusted Patient Day |
3.3% |
|||||
Behavioral Health Hospitals |
||||||
Revenues |
3.8% |
|||||
Adjusted Admissions |
-1.9% |
|||||
Adjusted Patient Days |
-1.3% |
|||||
Revenue Per Adjusted Admission |
5.8% |
|||||
Revenue Per Adjusted Patient Day |
5.1% |
|||||
UHS Consolidated |
First Quarter Ended |
|||||
3/31/2022 |
3/31/2021 |
|||||
Revenues |
$3,292,956 |
$3,012,987 |
||||
EBITDA net of NCI |
$368,332 |
$426,258 |
||||
EBITDA Margin net of NCI |
11.2% |
14.1% |
||||
Adjusted EBITDA net of NCI |
$379,533 |
$427,093 |
||||
Adjusted EBITDA Margin net of NCI |
11.5% |
14.2% |
||||
Cash Flow From Operations |
$445,433 |
$71,795 |
||||
Days Sales Outstanding |
48 |
50 |
||||
Capital Expenditures |
$200,002 |
$247,459 |
||||
Debt |
$4,299,175 |
$3,613,103 |
||||
UHS' Shareholders Equity |
$5,867,872 |
$6,513,862 |
||||
Debt / Total Capitalization |
42.3% |
35.7% |
||||
Debt / EBITDA net of NCI (1) (2) |
2.32 |
1.87 |
||||
Debt / Adjusted EBITDA net of NCI (1) (2) |
2.32 |
1.87 |
||||
Debt / Cash From Operations (1) (2) |
3.42 |
1.87 |
||||
(1) Latest 4 quarters. |
||||||
(2) For the three months ended March 31, 2021, Debt, net of approximately $749 million of short-term cash |
||||||
investments, resulted in ratios of 1.48 for each of Net Debt/EBITDA net of NCI, Net Debt/Adjusted EBITDA |
||||||
net of NCI, and Net Debt/Cash from Operations. |
||||||
Universal Health Services, Inc. |
||||||||||||||||||
Acute Care Hospital Services |
||||||||||||||||||
For the Three months ended |
||||||||||||||||||
March 31, 2022 and 2021 |
||||||||||||||||||
(in thousands) |
||||||||||||||||||
Same Facility Basis - Acute Care Hospital Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,834,779 |
100.0% |
$1,671,836 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
820,210 |
44.7% |
706,811 |
42.3% |
||||||||||||||
Other operating expenses |
437,477 |
23.8% |
393,207 |
23.5% |
||||||||||||||
Supplies expense |
313,137 |
17.1% |
296,478 |
17.7% |
||||||||||||||
Depreciation and amortization |
92,939 |
5.1% |
81,184 |
4.9% |
||||||||||||||
Lease and rental expense |
17,715 |
1.0% |
20,112 |
1.2% |
||||||||||||||
Subtotal-operating expenses |
1,681,478 |
91.6% |
1,497,792 |
89.6% |
||||||||||||||
Income from operations |
153,301 |
8.4% |
174,044 |
10.4% |
||||||||||||||
Interest expense, net |
638 |
0.0% |
246 |
0.0% |
||||||||||||||
Other (income) expense, net |
201 |
0.0% |
- |
- |
||||||||||||||
Income before income taxes |
$152,462 |
8.3% |
$173,798 |
10.4% |
||||||||||||||
All Acute Care Hospital Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,912,316 |
100.0% |
$1,694,542 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
843,906 |
44.1% |
707,218 |
41.7% |
||||||||||||||
Other operating expenses |
482,078 |
25.2% |
416,007 |
24.5% |
||||||||||||||
Supplies expense |
321,427 |
16.8% |
296,479 |
17.5% |
||||||||||||||
Depreciation and amortization |
94,534 |
4.9% |
81,362 |
4.8% |
||||||||||||||
Lease and rental expense |
20,852 |
1.1% |
20,112 |
1.2% |
||||||||||||||
Subtotal-operating expenses |
1,762,797 |
92.2% |
1,521,178 |
89.8% |
||||||||||||||
Income from operations |
149,519 |
7.8% |
173,364 |
10.2% |
||||||||||||||
Interest expense, net |
638 |
0.0% |
246 |
0.0% |
||||||||||||||
Other (income) expense, net |
201 |
0.0% |
- |
- |
||||||||||||||
Income before income taxes |
$148,680 |
7.8% |
$173,118 |
10.2% |
||||||||||||||
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2021. |
||||||||||||||||||
The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months. |
||||||||||||||||||
Universal Health Services, Inc. |
||||||||||||||||||
Behavioral Health Care Services |
||||||||||||||||||
For the Three months ended |
||||||||||||||||||
March 31, 2022 and 2021 |
||||||||||||||||||
(in thousands) |
||||||||||||||||||
Same Facility - Behavioral Health Care Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,334,532 |
100.0% |
$1,285,977 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
745,806 |
55.9% |
698,228 |
54.3% |
||||||||||||||
Other operating expenses |
265,691 |
19.9% |
244,365 |
19.0% |
||||||||||||||
Supplies expense |
49,597 |
3.7% |
50,513 |
3.9% |
||||||||||||||
Depreciation and amortization |
44,731 |
3.4% |
45,090 |
3.5% |
||||||||||||||
Lease and rental expense |
10,724 |
0.8% |
11,251 |
0.9% |
||||||||||||||
Subtotal-operating expenses |
1,116,549 |
83.7% |
1,049,447 |
81.6% |
||||||||||||||
Income from operations |
217,983 |
16.3% |
236,530 |
18.4% |
||||||||||||||
Interest expense, net |
465 |
0.0% |
338 |
0.0% |
||||||||||||||
Other (income) expense, net |
(115) |
(0.0)% |
413 |
0.0% |
||||||||||||||
Income before income taxes |
217,633 |
16.3% |
$235,779 |
18.3% |
||||||||||||||
All Behavioral Health Care Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,366,467 |
100.0% |
$1,315,337 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
753,886 |
55.2% |
703,975 |
53.5% |
||||||||||||||
Other operating expenses |
298,467 |
21.8% |
269,297 |
20.5% |
||||||||||||||
Supplies expense |
50,178 |
3.7% |
51,009 |
3.9% |
||||||||||||||
Depreciation and amortization |
46,079 |
3.4% |
46,482 |
3.5% |
||||||||||||||
Lease and rental expense |
10,820 |
0.8% |
11,683 |
0.9% |
||||||||||||||
Subtotal-operating expenses |
1,159,430 |
84.8% |
1,082,446 |
82.3% |
||||||||||||||
Income from operations |
207,037 |
15.2% |
232,891 |
17.7% |
||||||||||||||
Interest expense, net |
1,365 |
0.1% |
1,153 |
0.1% |
||||||||||||||
Other (income) expense, net |
(115) |
(0.0)% |
413 |
0.0% |
||||||||||||||
Income before income taxes |
205,787 |
15.1% |
$231,325 |
17.6% |
||||||||||||||
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments, lawsuits and reserves established in connection with the government's investigation of our behavioral health care facilities, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and in the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2021. |
||||||||||||||||||
The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months as well as the results of certain facilities that were closed or restructured during the past year. |
||||||||||||||||||
Universal Health Services, Inc. |
||||||||||||
Selected Hospital Statistics |
||||||||||||
For the Three months ended |
||||||||||||
March 31, 2022 and 2021 |
||||||||||||
AS REPORTED: |
||||||||||||
ACUTE |
BEHAVIORAL HEALTH |
|||||||||||
3/31/22 |
3/31/21 |
% change |
3/31/22 |
3/31/21 |
% change |
|||||||
Hospitals owned and leased |
27 |
26 |
3.8% |
336 |
335 |
0.3% |
||||||
Average licensed beds |
6,749 |
6,515 |
3.6% |
24,243 |
24,018 |
0.9% |
||||||
Average available beds |
6,577 |
6,343 |
3.7% |
24,143 |
23,918 |
0.9% |
||||||
Patient days |
405,952 |
392,391 |
3.5% |
1,506,351 |
1,534,162 |
-1.8% |
||||||
Average daily census |
4,510.6 |
4,359.9 |
3.5% |
16,737.2 |
17,046.2 |
-1.8% |
||||||
Occupancy-licensed beds |
66.8% |
66.9% |
-0.1% |
69.0% |
71.0% |
-2.8% |
||||||
Occupancy-available beds |
68.6% |
68.7% |
-0.2% |
69.3% |
71.3% |
-2.8% |
||||||
Admissions |
75,289 |
72,924 |
3.2% |
112,433 |
115,408 |
-2.6% |
||||||
Length of stay |
5.4 |
5.4 |
-0.1% |
13.4 |
13.3 |
0.7% |
||||||
Inpatient revenue |
$10,239,231 |
$9,119,184 |
12.3% |
$2,436,474 |
$2,473,565 |
-1.5% |
||||||
Outpatient revenue |
5,775,539 |
4,580,720 |
26.1% |
257,113 |
246,764 |
4.2% |
||||||
Total patient revenue |
16,014,770 |
13,699,904 |
16.9% |
2,693,587 |
2,720,329 |
-1.0% |
||||||
Other revenue |
184,481 |
143,265 |
28.8% |
66,697 |
62,208 |
7.2% |
||||||
Gross hospital revenue |
16,199,251 |
13,843,169 |
17.0% |
2,760,284 |
2,782,537 |
-0.8% |
||||||
Total deductions |
14,286,935 |
12,148,627 |
17.6% |
1,393,817 |
1,467,200 |
-5.0% |
||||||
Net hospital revenue |
$1,912,316 |
$1,694,542 |
12.9% |
$1,366,467 |
$1,315,337 |
3.9% |
||||||
SAME FACILITY: |
||||||||||||
ACUTE |
BEHAVIORAL HEALTH |
|||||||||||
3/31/22 |
3/31/21 |
% change |
3/31/22 |
3/31/21 |
% change |
|||||||
Hospitals owned and leased |
26 |
26 |
0.0% |
331 |
331 |
0.0% |
||||||
Average licensed beds |
6,683 |
6,515 |
2.6% |
23,841 |
23,725 |
0.5% |
||||||
Average available beds |
6,511 |
6,343 |
2.6% |
23,741 |
23,625 |
0.5% |
||||||
Patient days |
402,165 |
392,391 |
2.5% |
1,493,766 |
1,519,290 |
-1.7% |
||||||
Average daily census |
4,468.5 |
4,359.9 |
2.5% |
16,597.4 |
16,881.0 |
-1.7% |
||||||
Occupancy-licensed beds |
66.9% |
66.9% |
-0.1% |
69.6% |
71.2% |
-2.2% |
||||||
Occupancy-available beds |
68.6% |
68.7% |
-0.2% |
69.9% |
71.5% |
-2.2% |
||||||
Admissions |
74,933 |
72,924 |
2.8% |
111,084 |
113,708 |
-2.3% |
||||||
Length of stay |
5.4 |
5.4 |
-0.3% |
13.4 |
13.4 |
0.6% |
||||||
SOURCE Universal Health Services, Inc.
Консолидированные результаты деятельности, Как указано в Отчете, и Скорректированные – Трехмесячные периоды, закончившиеся 31 марта 2022 и 2021 годов:
КОРОЛЬ ПРУССИИ, Пенсильвания, 25 апреля 2022 г. /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) объявила сегодня, что ее чистая прибыль, относящаяся к UHS, составила 153,9 млн долларов, или 2,02 доллара на разводненную акцию, в первом квартале 2022 г. по сравнению с 209,1 млн долларов, или 2,43 доллара на разводненную акцию в течение первого квартала 2021 года. Чистая выручка увеличилась на 9,3% до 3,293 миллиарда долларов в первом квартале 2022 года по сравнению с 3,013 миллиарда долларов в первом квартале 2021 года.
Как отражено в Таблице дополнительной информации, не относящейся к GAAP ("Дополнительная таблица"), наша скорректированная чистая прибыль, относящаяся к UHS, в первом квартале 2022 года составила 163,5 млн долларов, или 2,15 доллара на разводненную акцию, по сравнению с 210,1 млн долларов, или 2,44 доллара на разводненную акцию, в первом квартале квартал 2021 года.
Как отражено в Дополнительном графике, включенном в наши отчетные результаты за первый квартал 2022 года, был неблагоприятный нереализованный убыток после налогообложения в размере 9,5 млн долларов, или 0,13 доллара на разводненную акцию (12,5 млн долларов до налогообложения, которые включены в "Прочие (доходы) расходы, нетто"), возникающий в результате снижения рыночной стоимости определенных долевых ценных бумаг.
Как отражено в Дополнительном графике, включенном в наши отчетные результаты за первый квартал 2021 года, чистое совокупное неблагоприятное влияние после уплаты налогов составило 1,1 миллиона долларов, или 0,01 доллара на разводненную акцию, состоящее из следующего: (i) нереализованный убыток после уплаты налогов в размере 2,1 миллиона долларов, или 0,02 доллара на разводненную акцию (2,8 миллиона долларов до налогообложения, которые включены в "Прочие (доходы) расходы, нетто"), в результате снижения рыночной стоимости определенных долевых ценных бумаг и; (ii) благоприятное влияние после уплаты налогов в размере 1,1 миллиона долларов, или 0,01 доллара на разводненную акцию, в соответствии с ASU 2016-09, "Компенсация – Компенсация акций (Тема 718): Улучшения в учете выплат на основе акций сотрудников" ("ASU 2016-09").
Как рассчитано в прилагаемом Дополнительном графике, наша прибыль до вычета процентов, налогов, износа и амортизации ("EBITDA за вычетом NCI", NCI - чистая прибыль, приходящаяся на неконтролирующие доли участия), составила 368,3 млн долларов США в первом квартале 2022 года по сравнению с 426,3 млн долларов США в первом квартале 2021 года. Наша скорректированная прибыль до вычета процентов, налогов, износа и амортизации ("Скорректированная EBITDA за вычетом NCI"), которая исключает влияние прочих (доходных) расходов, нетто, составила 379,5 млн долларов США в первом квартале 2022 года по сравнению с 427,1 млн долларов США в первом квартале 2021 года.
Неотложная медицинская помощь – Трехмесячные периоды, закончившиеся 31 марта 2022 и 2021 годов:
В течение первого квартала 2022 года в наших больницах неотложной помощи, принадлежащих в течение обоих периодов ("на базе одного и того же учреждения"), скорректированные поступления (с поправкой на амбулаторную деятельность) увеличились на 5,7%, а скорректированные дни пребывания пациентов увеличились на 5,5% по сравнению с первым кварталом 2021 года. В этих учреждениях в течение первого квартала 2022 года чистый доход на скорректированный прием увеличился на 3,1%, а чистый доход на скорректированный день приема пациентов увеличился на 3,3% по сравнению с первым кварталом 2021 года. Чистая выручка, полученная от наших услуг неотложной помощи в том же учреждении, увеличилась на 9,7% в течение первого квартала 2022 года по сравнению с первым кварталом 2021 года.
Услуги в области поведенческого здравоохранения – Трехмесячные периоды, закончившиеся 31 марта 2022 и 2021 годов:
В течение первого квартала 2022 года в учреждениях поведенческого здравоохранения на базе того же учреждения скорректированные поступления сократились на 1,9%, а скорректированные дни пребывания пациентов сократились на 1,3% по сравнению с первым кварталом 2021 года. В этих учреждениях в течение первого квартала 2022 года чистый доход на скорректированный прием увеличился на 5,8%, а чистый доход на скорректированный день приема пациентов увеличился на 5,1% по сравнению с первым кварталом 2021 года. Чистая выручка, полученная от наших услуг в области поведенческого здравоохранения, увеличилась на 3,8% в течение первого квартала 2022 года по сравнению с первым кварталом 2021 года.
Последствия пандемии COVID-19, начавшейся во второй половине марта 2020 года, с тех пор оказали существенное влияние на нашу деятельность и финансовые результаты. Процесс вакцинации против COVID-19 начался в первом квартале 2021 года. С того времени и до второго квартала 2021 года мы в целом наблюдали снижение числа пациентов с COVID-19, а также соответствующее восстановление активности пациентов, не страдающих COVID. Однако в течение третьего и четвертого кварталов 2021 года и в начале первого квартала 2022 года в наших учреждениях в целом наблюдалось увеличение числа пациентов с COVID-19, вызванных вирусом Дельта, а в последнее время и высокопередающимися вариантами Омикрона. Количество пациентов, связанных с COVID-19, в наших учреждениях, как правило, снижалось во второй половине первого квартала 2022 года.
Общенациональная нехватка медсестер и другого клинического персонала и вспомогательного персонала была серьезной операционной проблемой, с которой столкнулись мы и другие поставщики медицинских услуг. Как и другие работники отрасли здравоохранения, мы по-прежнему испытываем нехватку медсестер и другого клинического персонала, а также вспомогательного персонала в наших больницах неотложной помощи и поведенческого здравоохранения во многих географических регионах. В некоторых областях нехватка рабочей силы создает нагрузку на наши ресурсы и персонал, что требует от нас использования более дорогостоящей временной рабочей силы и выплаты премий сверх стандартной компенсации основным работникам. Эта нехватка персонала вынудила нас нанять дорогостоящий временный персонал и / или повысить заработную плату и льготы для найма и удержания медсестер и другого клинического персонала и вспомогательного персонала. В некоторых учреждениях, особенно в нашем сегменте поведенческого здравоохранения, мы не смогли заполнить все вакантные должности и, следовательно, были вынуждены ограничить количество пациентов. Эти факторы оказали существенное неблагоприятное влияние на наши результаты деятельности в первом квартале 2022 года. Продолжительность и масштабы сбоев, вызванных пандемией COVID–19, в настоящее время неизвестны; однако мы ожидаем, что такие сбои продолжатся в течение 2022 года.
Поскольку будущие объемы и тяжесть заболевания пациентов с COVID-19 остаются крайне неопределенными и могут измениться, включая потенциальное увеличение числа пациентов с COVID-19 в будущем, вызванное новыми вариантами вируса, а также связанным с этим давлением на персонал и ставки заработной платы, мы не в состоянии полностью количественно оценить влияние этих факторов окажет влияние на наши будущие финансовые результаты. Однако события, связанные с пандемией COVID-19, могут по-прежнему оказывать существенное влияние на наши финансовые показатели в течение 2022 года.
Чистые денежные средства, полученные от Операционной деятельности и Ликвидности:
Чистые денежные средства, полученные от операционной деятельности:
За три месяца, закончившихся 31 марта 2022 года, наши чистые денежные средства, полученные от операционной деятельности, составили 445 миллионов долларов по сравнению с 72 миллионами долларов в первом квартале 2021 года. Чистое увеличение наших чистых денежных средств от операционной деятельности в первом квартале 2022 года на 374 миллиона долларов по сравнению с первым кварталом 2021 года было обусловлено: (i) благоприятным изменением на 510 миллионов долларов, главным образом в результате досрочного возврата ускоренных платежей по программе Medicare, которые были получены в течение 2020 года и погашено в течение первого квартала 2021 года, частично компенсировано; (ii) неблагоприятным изменением дебиторской задолженности на 72 миллиона долларов США; (iii) неблагоприятным изменением на 44 миллиона долларов США в результате снижения чистой прибыли плюс расходы на износ и амортизацию, расходы на компенсацию на основе запасов и прибыль/убыток от продаж активов и предприятий, и; (iv) 20 миллионов долларов США других совокупных чистых неблагоприятных изменений.
По состоянию на 31 марта 2022 года совокупный доступный объем заимствований у нас составлял 736 миллионов долларов в соответствии с нашей возобновляемой кредитной линией на сумму 1,2 миллиарда долларов, за вычетом непогашенных займов и аккредитивов.
Программа Обратного выкупа Акций:
Как было объявлено ранее, 24 февраля 2022 года наш Совет директоров одобрил увеличение нашей программы обратного выкупа акций на 1,4 миллиарда долларов. В соответствии с этой программой, акции наших Обыкновенных акций класса В могут быть выкуплены, время от времени, если позволяют условия, на открытом рынке или в рамках согласованных частных сделок.
В течение первого квартала 2022 года мы выкупили около 2,65 млн акций общей стоимостью около 350,2 млн долларов (примерно 132 доллара за акцию). По состоянию на 31 марта 2022 года у нас было совокупное доступное разрешение на выкуп примерно на 1,41 миллиарда долларов.
Прогноз операционных результатов на 2022 год:
24 февраля 2022 года мы представили наш прогноз операционных результатов на 2022 год в рамках объявления наших финансовых результатов за четвертый квартал 2021 года и за весь год. Как сообщалось в то время, поскольку будущие объемы и тяжесть заболевания пациентов с COVID-19 остаются крайне неопределенными и могут измениться, а также давление на штатное расписание и ставки заработной платы, мы не можем полностью количественно оценить влияние, которое эти факторы окажут на наши будущие финансовые результаты.
Наши операционные результаты в первом квартале 2022 года отражают сохраняющуюся неопределенность, связанную с пандемией COVID-19, а также рост расходов, связанный с общенациональной нехваткой медсестер и другого клинического персонала и вспомогательного персонала. В результате наши затраты на рабочую силу оказались выше, чем ожидалось, а количество пациентов в наших учреждениях поведенческого здравоохранения оказалось ниже, чем ожидалось, что неблагоприятно сказалось на наших операционных результатах в первом квартале 2022 года.
В настоящее время мы не меняем наш ранее опубликованный прогноз операционных результатов на 2022 год. Однако, учитывая сохраняющуюся неопределенность, связанную с пандемией COVID-19, а также нехватку персонала в сфере здравоохранения и ее неблагоприятное влияние на наши затраты на рабочую силу и количество пациентов с поведенческим здоровьем, мы можем сократить наш прогноз операционных результатов на весь 2022 год в будущем, если неблагоприятные операционные тенденции, наблюдавшиеся в течение первого квартал 2022 года не улучшается.
Информация о конференц-звонке:
Мы проведем телефонную конференцию для инвесторов и аналитиков в 9:00 утра по восточному времени 26 апреля 2022 года. Набираемый номер - 1-877-648-7971.
Прямая трансляция телефонной конференции будет доступна на нашем веб-сайте по адресу www.uhs.com . Кроме того, повтор вызова будет доступен после завершения прямого вызова и будет доступен в течение одного полного года.
Общая информация, Прогнозные заявления и Факторы риска, а также Финансовые показатели, не относящиеся к GAAP:
Один из крупнейших и наиболее уважаемых в стране поставщиков больничных и медицинских услуг, Universal Health Services, Inc. имеет впечатляющий послужной список достижений и производительности. Неуклонно растущий с момента нашего превращения в уважаемую корпорацию из списка Fortune 500, наш годовой доход в течение 2021 года составил примерно 12,6 миллиарда долларов. В 2022 году UHS снова была признана Fortune одной из самых уважаемых компаний в мире, а в 2021 году компания заняла 270-е место в списке Fortune 500 и 307-е место в списке крупнейших публичных компаний Америки по версии Forbes.
Наша операционная философия сегодня так же эффективна, как и при основании Компании в 1979 году, что позволяет нам оказывать сострадательную помощь нашим пациентам и их близким. Наша стратегия включает в себя строительство или приобретение высококачественных больниц на быстрорастущих рынках, инвестиции в персонал и оборудование, необходимые для процветания каждого учреждения, и становление ведущим поставщиком медицинских услуг в каждом сообществе, которое мы обслуживаем.
Штаб-квартира UHS находится в Кинг-оф-Пруссия, штат Пенсильвания, и насчитывает более 89 000 сотрудников. Через свои дочерние компании она управляет 28 больницами неотложной помощи (включая недавно построенный медицинский центр Northern Nevada Sierra Medical Center на 170 коек, расположенный в Рино, штат Невада, который открылся в начале апреля 2022 года), 336 учреждениями поведенческого здоровья, 40 амбулаторными учреждениями и пункты доступа к амбулаторной помощи, страховое предложение, сеть врачей и различные сопутствующие услуги, расположенные в 39 штатах США, Вашингтоне, округ Колумбия, Пуэрто-Рико и Соединенном Королевстве. Он выступает в качестве консультанта Universal Health Realty Income Trust, инвестиционного фонда недвижимости (NYSE:UHT). Для получения дополнительной информации посетите www.uhs.com .
Настоящий пресс-релиз содержит прогнозные заявления, основанные на текущих ожиданиях руководства. Многочисленные факторы, в том числе раскрытые здесь, связанные с ожидаемым воздействием COVID-19 на нашу деятельность и финансовые результаты, связанные с тенденциями в отрасли здравоохранения и подробно описанные в наших заявках в Комиссию по ценным бумагам и биржам (как указано в Пункте 1A - Факторы риска и в Пункте 7 - Прогноз -Прогнозные заявления и факторы риска в нашей Форме 10-K за год, закончившийся 31 декабря 2021 года), могут привести к тому, что результаты будут существенно отличаться от ожидаемых в прогнозных заявлениях. Эти заявления подвержены рискам и неопределенностям, и поэтому фактические результаты могут существенно отличаться. Читатели не должны чрезмерно полагаться на такие прогнозные заявления, которые отражают точку зрения руководства только на дату настоящего Документа. Мы не берем на себя никаких обязательств пересматривать или обновлять какие-либо прогнозные заявления или делать какие-либо другие прогнозные заявления, будь то в результате новой информации, будущих событий или иным образом. Многие факторы, которые могут повлиять на наши будущие результаты, находятся вне нашего контроля или способности предсказать, включая последствия пандемии COVID-19. Наши будущие операции и финансовые результаты, вероятно, будут существенно затронуты события, связанные с COVID-19, в том числе, но не ограничиваясь, возможное влияние на будущее COVID-19 пациент объемов, вытекающих из новых вариантов вируса, продолжительности и тяжести распространения пандемии; объем отменены или перенесены на выборные процедуры и объем COVID-19 пациентов, проходивших лечение в наших больницах и других медицинских мероприятий; меры, которые мы предпринимаем для реагирования на COVID-19 пандемией; влияния государственного и административного регулирования и стимулирования в больнице отрасли и потенциал ретроспективной корректировки в будущие периоды забот закона и других безвозмездных поступлений доходов учитываются как доходы в предыдущие периоды; снижение пациента объемы и неблагоприятных изменений плательщика смешать в связи с ухудшением макроэкономических условий (в том числе увеличение незастрахованных и недостаточно застрахованных пациентов в результате закрытия предприятий и увольнений); потенциальных перебоев в нашем клинического персонала и дефицит и перебои в работе, связанные с поставками, необходимыми для наших сотрудников и пациентов; потенциальный рост расходов и других расходов на персонал, цепочки поставок, работ и медицинского оборудования, затрат и других расходов в результате инфляции; влияние существенной задолженности и возможность рефинансировать такой задолженности на приемлемых условиях, а также риски, связанные с перебоями в работе финансовых рынков и деятельности финансовых институтов в результате COVID-19 пандемией, которая может повлиять на нас с финансовой точки зрения; а также изменениями в общей экономической ситуации на национальном и региональном уровнях на наших рынках в результате COVID-19 пандемией. Мы не в состоянии полностью количественно оценить влияние, которое эти факторы окажут на наши будущие финансовые результаты, но события, связанные с пандемией COVID-19, могут продолжать оказывать существенное влияние на наши финансовые показатели в течение 2022 года.
Мы считаем, что скорректированная чистая прибыль, приходящаяся на UHS, скорректированная чистая прибыль, приходящаяся на UHS на разводненную акцию, EBITDA за вычетом NCI и Скорректированная EBITDA за вычетом NCI, которые являются финансовыми показателями, не относящимися к GAAP ("GAAP" - общепринятые принципы бухгалтерского учета в Соединенных Штатах Америки), полезны для наших инвесторов как показатель нашей операционной эффективности. Кроме того, мы считаем, что, когда это применимо, сравнение и обсуждение наших финансовых результатов, основанных на этих показателях, как они рассчитаны, полезно для наших инвесторов, поскольку это нейтрализует влияние существенных статей, влияющих на нашу чистую прибыль, относящуюся к UHS, таких как изменения рыночной стоимости акций определенных долевых ценных бумаг и другие потенциальные материальные статьи, которые являются разовыми или неработоспособными по своей природе, включая, но не ограничиваясь, обесценение долгосрочных и нематериальных активов, резервы по различным вопросам, включая расчеты, судебные решения и судебные иски, расходы, связанные с погашением долга, прибыли /убытки от продажи активов и бизнеса, и другие суммы, которые могут быть отражены в финансовых отчетах за текущий или предыдущий год, относящихся к предыдущим периодам. Чтобы получить полное представление о наших финансовых результатах, эти показатели должны быть рассмотрены в связи с чистой прибылью, относящейся к UHS, определенной в соответствии с GAAP и представленной в сокращенной консолидированной финансовой отчетности и примечаниях к ней в настоящем отчете или в других наших заявках в Комиссию по ценным бумагам и биржам, включая наш Отчет о Форма 10-К за год, закончившийся 31 декабря 2021 года. Поскольку статьи, включенные или исключенные из этих показателей, являются важными компонентами для понимания и оценки финансовых показателей в соответствии с GAAP, эти показатели не следует рассматривать в качестве альтернативы чистой прибыли в качестве показателя наших операционных показателей или прибыльности. Поскольку эти показатели, как они представлены, не определены в соответствии с GAAP и, следовательно, подвержены различным расчетам, они могут быть несопоставимы с другими аналогичными показателями других компаний. Инвесторам рекомендуется использовать показатели GAAP при оценке наших финансовых показателей.
Universal Health Services, Inc. |
|||
Consolidated Statements of Income |
|||
(in thousands, except per share amounts) |
|||
(unaudited) |
|||
Three months |
|||
ended March 31, |
|||
2022 |
2021 |
||
Net revenues |
$3,292,956 |
$3,012,987 |
|
Operating charges: |
|||
Salaries, wages and benefits |
1,692,270 |
1,497,773 |
|
Other operating expenses |
820,934 |
709,708 |
|
Supplies expense |
371,073 |
347,110 |
|
Depreciation and amortization |
143,784 |
131,403 |
|
Lease and rental expense |
32,038 |
31,324 |
|
3,060,099 |
2,717,318 |
||
Income from operations |
232,857 |
295,669 |
|
Interest expense, net |
21,673 |
21,957 |
|
Other (income) expense, net |
11,201 |
835 |
|
Income before income taxes |
199,983 |
272,877 |
|
Provision for income taxes |
48,962 |
63,807 |
|
Net income |
151,021 |
209,070 |
|
Less: Net income (loss) attributable to |
|||
noncontrolling interests ("NCI") |
(2,892) |
(21) |
|
Net income attributable to UHS |
$153,913 |
$209,091 |
|
Basic earnings per share attributable to UHS (a) |
$2.05 |
$2.46 |
|
Diluted earnings per share attributable to UHS (a) |
$2.02 |
$2.43 |
|
Universal Health Services, Inc. |
|||
Footnotes to Consolidated Statements of Income |
|||
(in thousands, except per share amounts) |
|||
(unaudited) |
|||
Three months |
|||
(a) Earnings per share calculation: |
ended March 31, |
||
2022 |
2021 |
||
Basic and diluted: |
|||
Net income attributable to UHS |
$153,913 |
$209,091 |
|
Less: Net income attributable to unvested restricted share grants |
(249) |
(552) |
|
Net income attributable to UHS - basic and diluted |
$153,664 |
$208,539 |
|
Weighted average number of common shares - basic |
75,030 |
84,782 |
|
Basic earnings per share attributable to UHS: |
$2.05 |
$2.46 |
|
Weighted average number of common shares |
75,030 |
84,782 |
|
Add: Other share equivalents |
1,011 |
1,014 |
|
Weighted average number of common shares and equiv. - diluted |
76,041 |
85,796 |
|
Diluted earnings per share attributable to UHS: |
$2.02 |
$2.43 |
|
Universal Health Services, Inc. |
|||||||
Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule") |
|||||||
For the Three Months ended March 31, 2022 and 2021 |
|||||||
(in thousands, except per share amounts) |
|||||||
(unaudited) |
|||||||
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI") |
|||||||
Three months ended |
% Net |
Three months ended |
% Net |
||||
March 31, 2022 |
revenues |
March 31, 2021 |
revenues |
||||
Net income attributable to UHS |
$153,913 |
$209,091 |
|||||
Depreciation and amortization |
143,784 |
131,403 |
|||||
Interest expense, net |
21,673 |
21,957 |
|||||
Provision for income taxes |
48,962 |
63,807 |
|||||
EBITDA net of NCI |
$368,332 |
11.2% |
$426,258 |
14.1% |
|||
Other (income) expense, net |
11,201 |
835 |
|||||
Adjusted EBITDA net of NCI |
$379,533 |
11.5% |
$427,093 |
14.2% |
|||
Net revenues |
$3,292,956 |
$3,012,987 |
|||||
Calculation of Adjusted Net Income Attributable to UHS |
|||||||
Three months ended |
Three months ended |
||||||
March 31, 2022 |
March 31, 2021 |
||||||
Per |
Per |
||||||
Amount |
Diluted Share |
Amount |
Diluted Share |
||||
Net income attributable to UHS |
$153,913 |
$2.02 |
$209,091 |
$2.43 |
|||
Plus/minus after-tax adjustments: |
|||||||
Unrealized loss on equity securities |
9,537 |
0.13 |
2,137 |
0.02 |
|||
Impact of ASU 2016-09 |
- |
- |
(1,079) |
(0.01) |
|||
Subtotal adjustments |
9,537 |
0.13 |
1,058 |
0.01 |
|||
Adjusted net income attributable to UHS |
$163,450 |
$2.15 |
$210,149 |
$2.44 |
|||
Universal Health Services, Inc. |
|||
Consolidated Statements of Comprehensive Income |
|||
(in thousands) |
|||
(unaudited) |
|||
Three months |
|||
ended March 31, |
|||
2022 |
2021 |
||
Net income |
$151,021 |
$209,070 |
|
Other comprehensive income (loss): |
|||
Foreign currency translation adjustment |
(18,470) |
(10,346) |
|
Other comprehensive income (loss) before tax |
(18,470) |
(10,346) |
|
Income tax expense (benefit) related to items of other comprehensive income (loss) |
(944) |
(1,466) |
|
Total other comprehensive income (loss), net of tax |
(17,526) |
(8,880) |
|
Comprehensive income |
133,495 |
200,190 |
|
Less: Comprehensive income (loss) attributable to noncontrolling interests |
(2,892) |
(21) |
|
Comprehensive income attributable to UHS |
$136,387 |
$200,211 |
|
Universal Health Services, Inc. |
||||||
Condensed Consolidated Balance Sheets |
||||||
(in thousands) |
||||||
(unaudited) |
||||||
March 31, |
December 31, |
|||||
2022 |
2021 |
|||||
Assets |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
105,999 |
$ |
115,301 |
||
Accounts receivable, net |
1,754,877 |
1,746,635 |
||||
Supplies |
208,302 |
206,839 |
||||
Other current assets |
232,724 |
194,781 |
||||
Total current assets |
2,301,902 |
2,263,556 |
||||
Property and equipment |
10,929,292 |
10,770,702 |
||||
Less: accumulated depreciation |
(5,010,825) |
(4,896,427) |
||||
5,918,467 |
5,874,275 |
|||||
Other assets: |
||||||
Goodwill |
3,949,788 |
3,962,624 |
||||
Deferred income taxes |
47,549 |
45,707 |
||||
Right of use assets-operating leases |
368,921 |
367,477 |
||||
Deferred charges |
6,310 |
6,525 |
||||
Other |
551,509 |
573,379 |
||||
Total Assets |
$ |
13,144,446 |
$ |
13,093,543 |
||
Liabilities and Stockholders' Equity |
||||||
Current liabilities: |
||||||
Current maturities of long-term debt |
$ |
48,486 |
$ |
48,409 |
||
Accounts payable and other liabilities |
1,976,389 |
1,860,496 |
||||
Operating lease liabilities |
65,607 |
64,484 |
||||
Federal and state taxes |
55,734 |
10,720 |
||||
Total current liabilities |
2,146,216 |
1,984,109 |
||||
Other noncurrent liabilities |
475,006 |
464,759 |
||||
Operating lease liabilities noncurrent |
305,643 |
304,624 |
||||
Long-term debt |
4,250,689 |
4,141,879 |
||||
Redeemable noncontrolling interest |
4,314 |
5,119 |
||||
UHS common stockholders' equity |
5,867,872 |
6,089,664 |
||||
Noncontrolling interest |
94,706 |
103,389 |
||||
Total equity |
5,962,578 |
6,193,053 |
||||
Total Liabilities and Stockholders' Equity |
$ |
13,144,446 |
$ |
13,093,543 |
||
Universal Health Services, Inc. |
|||
Consolidated Statements of Cash Flows |
|||
(in thousands) |
|||
(unaudited) |
|||
Three months |
|||
ended March 31, |
|||
2022 |
2021 |
||
Cash Flows from Operating Activities: |
|||
Net income |
$151,021 |
$209,070 |
|
Adjustments to reconcile net income to net |
|||
cash provided by operating activities: |
|||
Depreciation & amortization |
143,784 |
131,403 |
|
Loss on sale of assets and businesses |
1,084 |
0 |
|
Stock-based compensation expense |
19,055 |
18,022 |
|
Changes in assets & liabilities, net of effects from |
|||
acquisitions and dispositions: |
|||
Accounts receivable |
(15,073) |
56,851 |
|
Accrued interest |
180 |
10,133 |
|
Accrued and deferred income taxes |
47,548 |
53,769 |
|
Other working capital accounts |
63,308 |
82,663 |
|
Medicare accelerated payments and deferred CARES Act and other grants |
250 |
(509,448) |
|
Other assets and deferred charges |
26,042 |
(17) |
|
Other |
(4,020) |
2,623 |
|
Accrued insurance expense, net of commercial premiums paid |
41,685 |
35,467 |
|
Payments made in settlement of self-insurance claims |
(29,431) |
(18,741) |
|
Net cash provided by operating activities |
445,433 |
71,795 |
|
Cash Flows from Investing Activities: |
|||
Property and equipment additions |
(200,002) |
(247,459) |
|
Proceeds received from sales of assets and businesses |
10,232 |
0 |
|
Inflows (outflows) from foreign exchange contracts that hedge our net U.K. investment |
20,710 |
(14,264) |
|
Decrease in capital reserves of commercial insurance subsidiary |
100 |
100 |
|
Costs incurred for purchase of information technology applications, net of refunds |
0 |
(575) |
|
Investment in, and advances to, joint ventures and other |
0 |
(129) |
|
Net cash used in investing activities |
(168,960) |
(262,327) |
|
Cash Flows from Financing Activities: |
|||
Repayments of long-term debt |
(11,966) |
(251,830) |
|
Additional borrowings |
117,400 |
0 |
|
Repurchase of common shares |
(365,505) |
(7,464) |
|
Dividends paid |
(14,875) |
(17,018) |
|
Issuance of common stock |
3,503 |
3,357 |
|
Profit distributions to noncontrolling interests |
(5,289) |
(4,525) |
|
Purchase (sale) of ownership interests by (from) minority members |
(1,307) |
7,603 |
|
Net cash used in financing activities |
(278,039) |
(269,877) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(2,232) |
423 |
|
Decrease in cash, cash equivalents and restricted cash |
(3,798) |
(459,986) |
|
Cash, cash equivalents and restricted cash, beginning of period |
178,934 |
1,279,154 |
|
Cash, cash equivalents and restricted cash, end of period |
$175,136 |
$819,168 |
|
Supplemental Disclosures of Cash Flow Information: |
|||
Interest paid |
$20,388 |
$11,421 |
|
Income taxes paid, net of refunds |
$4,423 |
$8,654 |
|
Noncash purchases of property and equipment |
$90,730 |
$60,124 |
|
Universal Health Services, Inc. |
||||||
Supplemental Statistical Information |
||||||
(unaudited) |
||||||
% Change |
||||||
3 Months ended |
||||||
Same Facility: |
3/31/2022 |
|||||
Acute Care Hospitals |
||||||
Revenues |
9.7% |
|||||
Adjusted Admissions |
5.7% |
|||||
Adjusted Patient Days |
5.5% |
|||||
Revenue Per Adjusted Admission |
3.1% |
|||||
Revenue Per Adjusted Patient Day |
3.3% |
|||||
Behavioral Health Hospitals |
||||||
Revenues |
3.8% |
|||||
Adjusted Admissions |
-1.9% |
|||||
Adjusted Patient Days |
-1.3% |
|||||
Revenue Per Adjusted Admission |
5.8% |
|||||
Revenue Per Adjusted Patient Day |
5.1% |
|||||
UHS Consolidated |
First Quarter Ended |
|||||
3/31/2022 |
3/31/2021 |
|||||
Revenues |
$3,292,956 |
$3,012,987 |
||||
EBITDA net of NCI |
$368,332 |
$426,258 |
||||
EBITDA Margin net of NCI |
11.2% |
14.1% |
||||
Adjusted EBITDA net of NCI |
$379,533 |
$427,093 |
||||
Adjusted EBITDA Margin net of NCI |
11.5% |
14.2% |
||||
Cash Flow From Operations |
$445,433 |
$71,795 |
||||
Days Sales Outstanding |
48 |
50 |
||||
Capital Expenditures |
$200,002 |
$247,459 |
||||
Debt |
$4,299,175 |
$3,613,103 |
||||
UHS' Shareholders Equity |
$5,867,872 |
$6,513,862 |
||||
Debt / Total Capitalization |
42.3% |
35.7% |
||||
Debt / EBITDA net of NCI (1) (2) |
2.32 |
1.87 |
||||
Debt / Adjusted EBITDA net of NCI (1) (2) |
2.32 |
1.87 |
||||
Debt / Cash From Operations (1) (2) |
3.42 |
1.87 |
||||
(1) Latest 4 quarters. |
||||||
(2) For the three months ended March 31, 2021, Debt, net of approximately $749 million of short-term cash |
||||||
investments, resulted in ratios of 1.48 for each of Net Debt/EBITDA net of NCI, Net Debt/Adjusted EBITDA |
||||||
net of NCI, and Net Debt/Cash from Operations. |
||||||
Universal Health Services, Inc. |
||||||||||||||||||
Acute Care Hospital Services |
||||||||||||||||||
For the Three months ended |
||||||||||||||||||
March 31, 2022 and 2021 |
||||||||||||||||||
(in thousands) |
||||||||||||||||||
Same Facility Basis - Acute Care Hospital Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,834,779 |
100.0% |
$1,671,836 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
820,210 |
44.7% |
706,811 |
42.3% |
||||||||||||||
Other operating expenses |
437,477 |
23.8% |
393,207 |
23.5% |
||||||||||||||
Supplies expense |
313,137 |
17.1% |
296,478 |
17.7% |
||||||||||||||
Depreciation and amortization |
92,939 |
5.1% |
81,184 |
4.9% |
||||||||||||||
Lease and rental expense |
17,715 |
1.0% |
20,112 |
1.2% |
||||||||||||||
Subtotal-operating expenses |
1,681,478 |
91.6% |
1,497,792 |
89.6% |
||||||||||||||
Income from operations |
153,301 |
8.4% |
174,044 |
10.4% |
||||||||||||||
Interest expense, net |
638 |
0.0% |
246 |
0.0% |
||||||||||||||
Other (income) expense, net |
201 |
0.0% |
- |
- |
||||||||||||||
Income before income taxes |
$152,462 |
8.3% |
$173,798 |
10.4% |
||||||||||||||
All Acute Care Hospital Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,912,316 |
100.0% |
$1,694,542 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
843,906 |
44.1% |
707,218 |
41.7% |
||||||||||||||
Other operating expenses |
482,078 |
25.2% |
416,007 |
24.5% |
||||||||||||||
Supplies expense |
321,427 |
16.8% |
296,479 |
17.5% |
||||||||||||||
Depreciation and amortization |
94,534 |
4.9% |
81,362 |
4.8% |
||||||||||||||
Lease and rental expense |
20,852 |
1.1% |
20,112 |
1.2% |
||||||||||||||
Subtotal-operating expenses |
1,762,797 |
92.2% |
1,521,178 |
89.8% |
||||||||||||||
Income from operations |
149,519 |
7.8% |
173,364 |
10.2% |
||||||||||||||
Interest expense, net |
638 |
0.0% |
246 |
0.0% |
||||||||||||||
Other (income) expense, net |
201 |
0.0% |
- |
- |
||||||||||||||
Income before income taxes |
$148,680 |
7.8% |
$173,118 |
10.2% |
||||||||||||||
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2021. |
||||||||||||||||||
The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months. |
||||||||||||||||||
Universal Health Services, Inc. |
||||||||||||||||||
Behavioral Health Care Services |
||||||||||||||||||
For the Three months ended |
||||||||||||||||||
March 31, 2022 and 2021 |
||||||||||||||||||
(in thousands) |
||||||||||||||||||
Same Facility - Behavioral Health Care Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,334,532 |
100.0% |
$1,285,977 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
745,806 |
55.9% |
698,228 |
54.3% |
||||||||||||||
Other operating expenses |
265,691 |
19.9% |
244,365 |
19.0% |
||||||||||||||
Supplies expense |
49,597 |
3.7% |
50,513 |
3.9% |
||||||||||||||
Depreciation and amortization |
44,731 |
3.4% |
45,090 |
3.5% |
||||||||||||||
Lease and rental expense |
10,724 |
0.8% |
11,251 |
0.9% |
||||||||||||||
Subtotal-operating expenses |
1,116,549 |
83.7% |
1,049,447 |
81.6% |
||||||||||||||
Income from operations |
217,983 |
16.3% |
236,530 |
18.4% |
||||||||||||||
Interest expense, net |
465 |
0.0% |
338 |
0.0% |
||||||||||||||
Other (income) expense, net |
(115) |
(0.0)% |
413 |
0.0% |
||||||||||||||
Income before income taxes |
217,633 |
16.3% |
$235,779 |
18.3% |
||||||||||||||
All Behavioral Health Care Services |
||||||||||||||||||
Three months ended |
Three months ended |
|||||||||||||||||
March 31, 2022 |
March 31, 2021 |
|||||||||||||||||
Amount |
% of Net |
Amount |
% of Net |
|||||||||||||||
Net revenues |
$1,366,467 |
100.0% |
$1,315,337 |
100.0% |
||||||||||||||
Operating charges: |
||||||||||||||||||
Salaries, wages and benefits |
753,886 |
55.2% |
703,975 |
53.5% |
||||||||||||||
Other operating expenses |
298,467 |
21.8% |
269,297 |
20.5% |
||||||||||||||
Supplies expense |
50,178 |
3.7% |
51,009 |
3.9% |
||||||||||||||
Depreciation and amortization |
46,079 |
3.4% |
46,482 |
3.5% |
||||||||||||||
Lease and rental expense |
10,820 |
0.8% |
11,683 |
0.9% |
||||||||||||||
Subtotal-operating expenses |
1,159,430 |
84.8% |
1,082,446 |
82.3% |
||||||||||||||
Income from operations |
207,037 |
15.2% |
232,891 |
17.7% |
||||||||||||||
Interest expense, net |
1,365 |
0.1% |
1,153 |
0.1% |
||||||||||||||
Other (income) expense, net |
(115) |
(0.0)% |
413 |
0.0% |
||||||||||||||
Income before income taxes |
205,787 |
15.1% |
$231,325 |
17.6% |
||||||||||||||
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments, lawsuits and reserves established in connection with the government's investigation of our behavioral health care facilities, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and in the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2021. |
||||||||||||||||||
The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months as well as the results of certain facilities that were closed or restructured during the past year. |
||||||||||||||||||
Universal Health Services, Inc. |
||||||||||||
Selected Hospital Statistics |
||||||||||||
For the Three months ended |
||||||||||||
March 31, 2022 and 2021 |
||||||||||||
AS REPORTED: |
||||||||||||
ACUTE |
BEHAVIORAL HEALTH |
|||||||||||
3/31/22 |
3/31/21 |
% change |
3/31/22 |
3/31/21 |
% change |
|||||||
Hospitals owned and leased |
27 |
26 |
3.8% |
336 |
335 |
0.3% |
||||||
Average licensed beds |
6,749 |
6,515 |
3.6% |
24,243 |
24,018 |
0.9% |
||||||
Average available beds |
6,577 |
6,343 |
3.7% |
24,143 |
23,918 |
0.9% |
||||||
Patient days |
405,952 |
392,391 |
3.5% |
1,506,351 |
1,534,162 |
-1.8% |
||||||
Average daily census |
4,510.6 |
4,359.9 |
3.5% |
16,737.2 |
17,046.2 |
-1.8% |
||||||
Occupancy-licensed beds |
66.8% |
66.9% |
-0.1% |
69.0% |
71.0% |
-2.8% |
||||||
Occupancy-available beds |
68.6% |
68.7% |
-0.2% |
69.3% |
71.3% |
-2.8% |
||||||
Admissions |
75,289 |
72,924 |
3.2% |
112,433 |
115,408 |
-2.6% |
||||||
Length of stay |
5.4 |
5.4 |
-0.1% |
13.4 |
13.3 |
0.7% |
||||||
Inpatient revenue |
$10,239,231 |
$9,119,184 |
12.3% |
$2,436,474 |
$2,473,565 |
-1.5% |
||||||
Outpatient revenue |
5,775,539 |
4,580,720 |
26.1% |
257,113 |
246,764 |
4.2% |
||||||
Total patient revenue |
16,014,770 |
13,699,904 |
16.9% |
2,693,587 |
2,720,329 |
-1.0% |
||||||
Other revenue |
184,481 |
143,265 |
28.8% |
66,697 |
62,208 |
7.2% |
||||||
Gross hospital revenue |
16,199,251 |
13,843,169 |
17.0% |
2,760,284 |
2,782,537 |
-0.8% |
||||||
Total deductions |
14,286,935 |
12,148,627 |
17.6% |
1,393,817 |
1,467,200 |
-5.0% |
||||||
Net hospital revenue |
$1,912,316 |
$1,694,542 |
12.9% |
$1,366,467 |
$1,315,337 |
3.9% |
||||||
SAME FACILITY: |
||||||||||||
ACUTE |
BEHAVIORAL HEALTH |
|||||||||||
3/31/22 |
3/31/21 |
% change |
3/31/22 |
3/31/21 |
% change |
|||||||
Hospitals owned and leased |
26 |
26 |
0.0% |
331 |
331 |
0.0% |
||||||
Average licensed beds |
6,683 |
6,515 |
2.6% |
23,841 |
23,725 |
0.5% |
||||||
Average available beds |
6,511 |
6,343 |
2.6% |
23,741 |
23,625 |
0.5% |
||||||
Patient days |
402,165 |
392,391 |
2.5% |
1,493,766 |
1,519,290 |
-1.7% |
||||||
Average daily census |
4,468.5 |
4,359.9 |
2.5% |
16,597.4 |
16,881.0 |
-1.7% |
||||||
Occupancy-licensed beds |
66.9% |
66.9% |
-0.1% |
69.6% |
71.2% |
-2.2% |
||||||
Occupancy-available beds |
68.6% |
68.7% |
-0.2% |
69.9% |
71.5% |
-2.2% |
||||||
Admissions |
74,933 |
72,924 |
2.8% |
111,084 |
113,708 |
-2.3% |
||||||
Length of stay |
5.4 |
5.4 |
-0.3% |
13.4 |
13.4 |
0.6% |
||||||
ИСТОЧНИК Universal Health Services, Inc.
Показать большеПоказать меньше
